--------------------------
Berthold
Reichardt
Reichardt__Berthold.JPG
Dipl.Ing.

Berthold Reichardt

Ltr. Behandlungsökonomie, ÖGK Österreichische Gesundheitskasse
Studium Biochemie an der Technischen Universität Wien 1977-1983
Pharmamarketing 1984-1998
Heilmittel- und Behandlungsökonomie in der Burgenländischen Gebietskrankenkasse ab 1999

Publikationen und Projekte (Auswahl)

Country-wide medical records infer increased allergy risk of gastric acid inhibition.
Jordakieva G, Kundi M, Untersmayr E, Pali-Schöll I, Reichardt B, Jensen-Jarolim E.
Nat Commun. 2019 Jul 30;10(1):3298

Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study.

Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E.
Bone Rep. 2019 Apr 1;10:100204

SSRI co-medication with NOAC or VKA does not increase hospitalization for bleeding: A retrospective nation-wide cohort study in Austria 2010-2015.

Sheikh Rezaei S, Mittlböck M, Reichardt B, Wolzt M.
Int J Geriatr Psychiatry. 2019 Apr 9

Seasonality of antidepressant prescriptions and sick leaves
Winkler D, Reichardt B, Kranz GS, Bartova L, Kasper S, Pjrek E.
J Psychiatr Res. 2019 Jan 26;111:128-133

Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011 : A retrospective analysis of 72% of the population.
Stamm TA, Reichardt B, Zwerina J, Ritschl V, Nell-Duxneuner V.
Wien Klin Wochenschr. 2018 Feb 14

Epidemiology of Multiple Sclerosis in Austria
Salhofer-Polanyi S, Cetin H, Leutmezer F, Baumgartner A, Blechinger S, Dal-Bianco A, Altmann P, Bajer-Kornek B, Rommer P, Guger M, Leitner-Bohn D, Reichardt B, Alasti F, Temsch W, Stamm T
Neuroepidemiology 2017;49:40-44

Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome: A nationwide long-term registry analysis from 2009 to 2014.
Sheikh Rezaei S, Geroldinger A, Heinze G, Reichardt B, Wolzt M.
Int J Cardiol. 2017 May 15;235:61-66

Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E.
Osteoporos Int. 2017 May;28(5):1587-1595

  • Newsletter abonnieren und informiert bleiben.abonnieren